title: How do we best measure the clinical benefit of a structure-modifying osteoarthritis drug?
authors.affiliation: Claude Bernard University Lyon, Service de Rhumatologie, Centre Hospitalier Lyon-Sud,165 chemin du Grand Revoyet, 69495 Pierre Benite Cedex, France. eric.vignon@chu-lyon.fr
authors.forename: Eric P
authors.initials: EP
authors.lastname: Vignon
authors.forename: Larry
authors.initials: L
authors.lastname: Moreland
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D010003:Osteoarthritis / Q000188:drug therapy*; D012107:Research Design; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents